About this episode

This episode discusses the safety profile of bDMARDs and JAK inhibitors in axSpA and PsA, the need for CAR-T testing, and strategies to enhance Methotrexate efficacy.

MACE and Safety Profile of bDMARDs/JAKis in axSpA and PsAHow Many CAR-Ts Do We Need to Test Drive?Making Methotrexate More Effective

People in this episode

Host: Dr. Cush

Topics covered

• bDMARDs
• JAK inhibitors
• axSpA
• PsA
• CAR-T therapy
• Methotrexate

Keywords

• bDMARDs
• JAK inhibitors
• axSpA
• PsA
• CAR-T
• Methotrexate
• safety profile
• treatment efficacy

Mentioned in this episode

Organizations: EULAR, axSpA, PsA

Products: bDMARDs, JAKis, CAR-Ts, Methotrexate

More episodes of Rheumnow Podcast

• RheumNow EULAR 2026 Rheumatology Round Up · June 12, 2026 · 56 min
• EULAR 2026 RA Topic Panel · June 11, 2026 · 54 min
• CAR-T Topic Panel EULAR 2026 · June 10, 2026 · 38 min
• EULAR 2026 PsA Update What's Changing in Psoriatic Arthritis Care? · June 9, 2026 · 49 min
• RA Topic Podcast compilation · June 8, 2026 · 1h 35m
• PsA Topic Podcast compilation · June 8, 2026 · 1h 37m

Explore listener stats, chart rankings, contacts and more on the Rheumnow Podcast podcast page.